Evidence map›Paper›PMID 35438522›Full record

ArticleAIDS patient care and STDs2022

Lost2PrEP: Understanding Reasons for Pre-Exposure Prophylaxis and Sexual Health Care Disengagement Among Men Who Have Sex with Men Attending a Sexual Health Clinic at a Large Urban Academic Medical Center in New York City.

Kelly Rowe, Deborah A Theodore, Jason Zucker, Omid Cohensedgh, Elijah LaSota, Caroline Carnevale, Alwyn Cohall, Susan Olender, Peter Gordon, Magdalena E Sobieszczyk

Open access · greenAbstract read
In one paragraph

Article in AIDS patient care and STDs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Kelly RoweDivision of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0002-5986-778X
Deborah A TheodoreDivision of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Jason ZuckerDivision of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0001-6987-6412
Omid CohensedghColumbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Elijah LaSotaDivision of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Caroline CarnevaleNYP HIV Prevention Program, New York-Presbyterian Hospital, New York, New York, USA.
Alwyn CohallMailman School of Public Health and Columbia University Irving Medical Center, New York, New York, USA.
Susan OlenderDivision of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Peter GordonDivision of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Magdalena E SobieszczykDivision of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Columbia University Irving Medical Center · USColumbia University · USNewYork–Presbyterian Hospital · US

Funding

Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials UnitUM1AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK · 2012 to 2026
$44.8M
Columbia Collaborative HIV/AIDS Clinical Trials UnitU01AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HAMMER, SCOTT M · 2007 to 2011
$15.4M
Harnessing Bioinformatics for HIV Prevention: Understanding Persistence in Comprehensive HIV Prevention ServicesK23AI150378 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZUCKER, JASON · 2020 to 2024
$960k
NIAID NIH HHS K23 AI150378NIAID NIH HHS L30 AI133789NIAID NIH HHS U01 AI069470NIAID NIH HHS UM1 AI069470
6 · The paper itself

Abstract

Pre-exposure prophylaxis (PrEP) prevents HIV, but low rates of retention in care limit its effectiveness. We conducted a prospective survey-based study to investigate reasons for PrEP disengagement among men who have sex with men attending a sexual health clinic at a large urban academic medical center in New York City who were lost to follow up; surveys asked about current PrEP status, reasons for disengagement, attitudes toward PrEP, substance use, sexual practices, and behavioral/social determinants of health. Outreach attempts were made to 634 patients; majority of eligible participants were unable to be contacted (59%). Among those who agreed to participate (

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesSexual HealthAcademic Medical CentersFemaleHomosexuality, MaleHumansMaleNew York CityProspective StudiesSexual BehaviorAnti-HIV Agentsengagement in careMSMpre-exposure prophylaxissexual health

Identifiers

PMID35438522
PMCPMC9057871
OpenAlexW4224224339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.